HLA-DR was upregulated on both the CD117+ and CD117− ILC subsets in the tumor (Fig. 1a; Supplementary Fig. 1c, d), while HLA-DR and CRTH2 expression, the latter marking human ILC27, was mutually exclusive (Supplementary Fig. 1b). The gene discussed is PTGDR2; the disease is neoplasm.